The NASDAQ Biotechnology Index contains securities of NASDAQ-listed companies classified according to the Industry Classification Benchmark as either Biotechnology or Pharmaceuticals which also meet other eligibility criteria. The NASDAQ Biotechnology Index is calculated under a modified capitalization-weighted methodology.
The Index began on November 1, 1993 at a base value of 200.00.
Last | 5,148.89 |
Net Change | -41.83 |
Net Change(%) | -0.81 |
Day High | 5,203.97 |
Day Low | 5,112.87 |
Previous Close | 5,190.72 |
Base Value | 200.00 |
# of Components | 280 |
Index Currency | USD |
Entitlement | U.S. Classic (NASDAQ / PHLX) |
Name | Symbol | Sponsor |
---|---|---|
ProShares Ultra NASDAQ Biotechnology ETF | BIB | ProShares Trust |
ProShares UltraShort NASDAQ Biotechnology ETF | BIS | ProShares Trust |
Invesco NASDAQ Biotech UCITS ETF | SBIO | Invesco PowerShares |
iShares Nasdaq Biotechnology Index Fund | IBB | BlackRock Institutional Trust Company, N.A. |
Capital NASDAQ Biotechnology Index Exchang Traded Fund | 678 | Capital Securities Inv Tst Co. |
ProShares UltraPro Nasdaq Biotechnology ETF | UBIO | ProShares Trust |
ProShares UltraProShort Nasdaq Biotechnology ETF | ZBIO | ProShares Trust |
Tachlit Nasdaq Biotechnology ILS | TCBI105 | Tachlit Trackers |
Mirae Asset TIGER Nasdaq BIO ETF | 203780 | Mirae Asset MAPS Global Investment Co., Ltd |